Metabolism - Clinical and Experimental
Volume 45, Issue 6 , Pages 686-690, June 1996

Very—low-density lipoprotein of uremic patients is a poor substrate for bovine lipoprotein lipase in vitro

  • Margret Arnadottir

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Margret Arnadottir, MD, PhD, Department of Medicine, National University Hospital, IS-101 Reykjavik, Iceland.
    • Departments of Nephrology and Clinical Chemistry, University Hospital, Lund, Sweden
    • INSERM U-325, Institut Pasteur, Lille, France
  • ,
  • Jean Dallongeville

      Affiliations

    • Departments of Nephrology and Clinical Chemistry, University Hospital, Lund, Sweden
    • INSERM U-325, Institut Pasteur, Lille, France
  • ,
  • Jean-Charles Fruchart

      Affiliations

    • Departments of Nephrology and Clinical Chemistry, University Hospital, Lund, Sweden
    • INSERM U-325, Institut Pasteur, Lille, France
  • ,
  • Peter Nilsson-Ehle

      Affiliations

    • Departments of Nephrology and Clinical Chemistry, University Hospital, Lund, Sweden
    • INSERM U-325, Institut Pasteur, Lille, France

Received 25 February 1994; accepted 29 November 1995.

Abstract 

Very—low-density lipoprotein (VLDL) from 10 hemodialysis patients and 10 healthy controls was studied with respect to the substrate characteristics for bovine milk lipoprotein lipase (LPL). Compared with the control subjects, the hemodialysis patients had significantly higher serum triglyceride and apolipoprotein B—associated apolipoprotein CIII concentrations (1.03 ± 0.31 v 1.98 ± 0.86 mmol/L and 0.004 ± 0.002 v 0.011 ± 0.005 g/L, respectively), lower serum high-density lipoprotein (HDL) cholesterol and apolipoprotein Al concentrations (1.33 ± 0.37 v 0.95 ± 0.31 mmol/L and 1.29 ± 0.25 v 1.09 ± 0.23 g/L, respectively), and lower postheparin plasma LPL activity (82 ± 24 v 35 ± 14 mU/mL). There were also significant increases in the relative fat content and diameter of VLDL particles from patients versus controls. VLDL was labeled with a fluorescent phospholipid analog, DHPE, and the rate of the lipolytic reaction with purified bovine milk LPL was estimated from the increase in fluorescence intensity at 490 nm. There was no significant difference between initial reaction velocities in the study groups, but VLDL particles from hemodialysis patients were lipolyzed to a significantly lesser extent than those from healthy controls (mean increase in fluorescence intensity after completion of the reaction, 95 ± 36 v 140 ± 43 arbitrary units). These results are in accordance with the accumulation of remnant particles reported to occur in uremia despite only a moderately increased serum triglyceride concentration.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Swedish Medical Research Council (04966), the Medical Faculty, University of Lund, and Påhlssons Foundation.

PII: S0026-0495(96)90132-8

Metabolism - Clinical and Experimental
Volume 45, Issue 6 , Pages 686-690, June 1996